The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 11, 2015
Filed:
Feb. 22, 2011
Applicants:
RU Chih C. Huang, Baltimore, MD (US);
Kotohiko Kimura, Baltimore, MD (US);
Inventors:
Ru Chih C. Huang, Baltimore, MD (US);
Kotohiko Kimura, Baltimore, MD (US);
Assignee:
The Johns Hopkins University, Baltimore, MD (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/09 (2006.01); A61K 31/553 (2006.01); A61K 31/7028 (2006.01); A61K 31/075 (2006.01); A61K 31/198 (2006.01); A61K 31/225 (2006.01); A61K 31/401 (2006.01); A61K 31/417 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/09 (2013.01); A61K 31/553 (2013.01); A61K 31/7028 (2013.01); A61K 31/075 (2013.01); A61K 31/198 (2013.01); A61K 31/225 (2013.01); A61K 31/401 (2013.01); A61K 31/417 (2013.01); A61K 45/06 (2013.01);
Abstract
Disclosed is a composition comprising a derivative of NDGA and 7-hydroxystaurosporine. The composition can be in a unit dose form or kit. Also disclosed are methods for achieving cytotoxicity, particularly of rapidly dividing cells such as cancer, by administering a composition of the invention. In various embodiments of the invention subjects with cancer achieve prolonged survival and/or diminution in the size of their malignancies and cancer metastasis.